Scarica l'app Stockscreener
6.90
8.32%
0.53
Pre-mercato:
6.94
0.04
+0.58%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MYGN Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$6.37
Aprire:
$6.42
Volume 24 ore:
2.12M
Relative Volume:
1.18
Capitalizzazione di mercato:
$642.01M
Reddito:
$823.60M
Utile/perdita netta:
$-116.00M
Rapporto P/E:
-5.3077
EPS:
-1.3
Flusso di cassa netto:
$-107.30M
1 W Prestazione:
+18.76%
1M Prestazione:
+76.47%
6M Prestazione:
-35.69%
1 anno Prestazione:
-75.64%
Intervallo 1D:
$6.31
$7.05
Intervallo di 1 settimana:
$5.78
$7.05
Portata 52W:
$3.76
$29.30
Myriad Genetics Inc Stock (MYGN) Company Profile
Nome
Myriad Genetics Inc
Settore
Industria
Telefono
801-584-3600
Indirizzo
322 NORTH 2200 WEST, SALT LAKE CITY, UT
Confronta MYGN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MYGN
Myriad Genetics Inc
|
6.90 | 592.69M | 823.60M | -116.00M | -107.30M | -1.30 |
|
TMO
Thermo Fisher Scientific Inc
|
487.53 | 186.06B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
203.79 | 147.38B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
639.45 | 51.77B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
125.21 | 35.62B | 6.79B | 1.22B | 1.09B | 4.26 |
|
IQV
Iqvia Holdings Inc
|
183.74 | 32.44B | 15.70B | 1.24B | 2.01B | 6.91 |
Myriad Genetics Inc Stock (MYGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-21 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| 2025-05-08 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2025-05-07 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2025-04-09 | Downgrade | Guggenheim | Buy → Neutral |
| 2025-03-12 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2025-02-12 | Iniziato | Craig Hallum | Buy |
| 2024-12-10 | Iniziato | UBS | Neutral |
| 2024-12-09 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-09-19 | Iniziato | Morgan Stanley | Equal-Weight |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-06-27 | Iniziato | Scotiabank | Sector Outperform |
| 2024-06-03 | Ripresa | Jefferies | Underperform |
| 2024-05-08 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2023-12-21 | Ripresa | Piper Sandler | Neutral |
| 2023-12-19 | Iniziato | Wells Fargo | Equal Weight |
| 2023-12-14 | Iniziato | Guggenheim | Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-07-05 | Ripresa | JP Morgan | Underweight |
| 2023-05-23 | Aggiornamento | Goldman | Sell → Buy |
| 2023-01-18 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2022-10-06 | Iniziato | Stephens | Equal-Weight |
| 2021-10-15 | Ripresa | Cowen | Market Perform |
| 2021-06-15 | Iniziato | Raymond James | Mkt Perform |
| 2021-06-03 | Iniziato | Goldman | Sell |
| 2019-09-26 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2019-08-14 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2019-08-02 | Aggiornamento | BofA/Merrill | Underperform → Neutral |
| 2019-08-01 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2019-07-29 | Downgrade | Needham | Strong Buy → Hold |
| 2019-07-09 | Downgrade | Cowen | Outperform → Market Perform |
| 2019-03-12 | Reiterato | Needham | Strong Buy |
| 2019-01-03 | Iniziato | Needham | Strong Buy |
| 2018-11-30 | Aggiornamento | Goldman | Sell → Neutral |
| 2018-10-10 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2018-07-11 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2018-03-21 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2018-01-29 | Iniziato | Goldman | Sell |
| 2018-01-22 | Reiterato | Barclays | Equal Weight |
| 2018-01-05 | Iniziato | BTIG Research | Buy |
| 2017-10-02 | Ripresa | Leerink Partners | Mkt Perform |
| 2017-08-09 | Reiterato | Barclays | Equal Weight |
| 2017-02-08 | Aggiornamento | Ladenburg Thalmann | Sell → Neutral |
| 2017-01-18 | Iniziato | Deutsche Bank | Sell |
| 2016-10-10 | Downgrade | Ladenburg Thalmann | Neutral → Sell |
Mostra tutto
Myriad Genetics Inc Borsa (MYGN) Ultime notizie
How to integrate Myriad Genetics Inc. into portfolio analysis toolsWeekly Investment Recap & Risk Controlled Daily Trade Plans - Newser
Analyzing recovery setups for Myriad Genetics Inc. investors2025 Institutional Moves & AI Powered Market Trend Analysis - Newser
Momentum divergence signals in Myriad Genetics Inc. chartEarnings Overview Summary & AI Forecast Swing Trade Picks - Newser
Combining machine learning predictions for Myriad Genetics Inc.2025 Top Decliners & Community Verified Trade Alerts - Newser
Relative strength of Myriad Genetics Inc. in sector analysis2025 Investor Takeaways & AI Powered Market Entry Ideas - Newser
Analyzing Myriad Genetics Inc. with multi timeframe charts2025 Year in Review & Growth Oriented Trade Recommendations - Newser
Is Myriad Genetics Inc. showing signs of accumulationJuly 2025 Patterns & Consistent Profit Alerts - Newser
Combining price and volume data for Myriad Genetics Inc.Weekly Gains Summary & Long-Term Capital Growth Ideas - Newser
Real time alert setup for Myriad Genetics Inc. performanceQuarterly Profit Review & Consistent Return Strategy Ideas - Newser
Can Myriad Genetics Inc. lead its sector in growthJuly 2025 Snapshot & Advanced Swing Trade Entry Alerts - خودرو بانک
Can Myriad Genetics Inc. outperform in the next rallyJuly 2025 Macro Moves & Fast Gaining Stock Strategy Reports - خودرو بانک
What chart patterns are forming on Myriad Genetics Inc.July 2025 Technicals & Weekly Market Pulse Alerts - خودرو بانک
Using portfolio simulators with Myriad Genetics Inc. includedMarket Volume Report & Growth Focused Investment Plans - Newser
Myriad Genetics Inc. stock trend forecastShort Setup & Daily Volume Surge Trade Alerts - Newser
How moving averages guide Myriad Genetics Inc. tradingWeekly Gains Summary & AI Forecast for Swing Trade Picks - Newser
Liquid Biopsy Market Trends and Industry Forecast to 2030 - GlobeNewswire
Liquid Biopsy Market Trends and Industry Forecast to 2030 Featuring Strategic Analysis of Natera, Guardant Health, Myriad Genetics, Illumina, and Roche Among Others - Yahoo Finance
Can volume confirm reversal in Myriad Genetics Inc.2025 Technical Patterns & Smart Investment Allocation Tips - Newser
Will Myriad Genetics Inc. continue its uptrendJuly 2025 Closing Moves & Consistent Income Trade Ideas - Newser
What recovery options are there for Myriad Genetics Inc.Weekly Trade Summary & Weekly Stock Performance Updates - Newser
How does Myriad Genetics Inc. compare to its peersJuly 2025 Big Picture & Detailed Earnings Play Strategies - خودرو بانک
Predicting Myriad Genetics Inc. trend using moving averages2025 Dividend Review & Consistent Return Strategy Ideas - Newser
How to use Fibonacci retracement on Myriad Genetics Inc.2025 Market Trends & Weekly Market Pulse Updates - Newser
What Fibonacci levels say about Myriad Genetics Inc. rebound2025 Technical Overview & Weekly High Return Stock Forecasts - Newser
Is Myriad Genetics Inc. stock entering bullish territoryShare Buyback & Verified Trade Idea Suggestions - Newser
Will Myriad Genetics Inc. see short term momentum2025 Trading Recap & Real-Time Chart Pattern Alerts - Newser
Can Myriad Genetics Inc. recover in the next quarter2025 Trading Recap & AI Driven Price Predictions - Newser
Custom strategy builders for tracking Myriad Genetics Inc.Dollar Strength & High Yield Equity Trading Tips - Newser
Using AI based signals to follow Myriad Genetics Inc.July 2025 Summary & Comprehensive Market Scan Reports - Newser
Myriad Genetics Inc. stock prediction for this weekMarket Rally & Weekly Stock Performance Updates - Newser
Published on: 2025-08-30 20:52:01 - Newser
How to monitor Myriad Genetics Inc. with trend dashboardsRisk Management & Precise Entry and Exit Recommendations - Newser
Historical volatility pattern of Myriad Genetics Inc. visualizedMarket Risk Report & Consistent Income Trade Recommendations - Newser
Myriad Genetics Inc Azioni (MYGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.76%
0.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):